Palvella Therapeutics Inc Sustainability Reports
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies for patients suffering from serious, rare genetic skin diseases. The company's pipeline revolves around its proprietary topical rapamycin platform, QTORIN.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 254900AJDH8PAOOI5T33
FIGI: BBG0055C3N66
1 reports from 2024 to 2024
